It must be noted that this can be a double-edged sword, and looking into side effects of BPC-157 is needed
10.1523/JNEUROSCI.0227-18.2019 26 CadavidD.MellionM.HuppertsR.EdwardsK
Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
PT-141: Sexual Desire Enhancement Targeted for Women PT-141 is FDA-approved for premenopausal women with hypoactive sexual desire disorder (HSDD)
I was like, you know, we talked about I think last time Barry how even though I'm a night owl, like I don't like being out super late